Cargando…
Knockout of STE20-type kinase TAOK3 does not attenuate diet-induced NAFLD development in mice
OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD), the primary hepatic consequence of obesity, is affecting about 25% of the global adult population. The aim of this study was to examine the in vivo role of STE20-type protein kinase TAOK3, which has been previously reported to regulate hepatocell...
Autores principales: | Xia, Ying, Andersson, Emma, Caputo, Mara, Cansby, Emmelie, Sedda, Francesca, Font-Gironès, Ferran, Ruud, Johan, Kurhe, Yeshwant, Hallberg, Bengt, Marschall, Hanns-Ulrich, Asterholm, Ingrid Wernstedt, Romeo, Stefano, Blüher, Matthias, Mahlapuu, Margit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589923/ https://www.ncbi.nlm.nih.gov/pubmed/37864157 http://dx.doi.org/10.1186/s10020-023-00738-y |
Ejemplares similares
-
STE20-type kinase TAOK3 regulates hepatic lipid partitioning
por: Xia, Ying, et al.
Publicado: (2021) -
STE20‐Type Protein Kinase MST4 Controls NAFLD Progression by Regulating Lipid Droplet Dynamics and Metabolic Stress in Hepatocytes
por: Caputo, Mara, et al.
Publicado: (2021) -
Silencing of STE20-type kinase TAOK1 confers protection against hepatocellular lipotoxicity through metabolic rewiring
por: Xia, Ying, et al.
Publicado: (2023) -
Protein kinase STK25 aggravates the severity of non-alcoholic fatty pancreas disease in mice
por: Nuñez-Durán, Esther, et al.
Publicado: (2017) -
Antagonizing STK25 Signaling Suppresses the Development of Hepatocellular Carcinoma Through Targeting Metabolic, Inflammatory, and Pro-Oncogenic Pathways
por: Kurhe, Yeshwant, et al.
Publicado: (2021)